4512.TSE · Wakamoto Pharmaceutical Co.,Ltd

-

Please sign in to comment on 4512.TSE

1 Comment

Admin

4 years ago

Wakamoto Pharmaceutical Co.,Ltd is currently in a long term uptrend where the price is trading 6.1% above its 200 day moving average.

From a valuation standpoint, the stock is 97.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.

Wakamoto Pharmaceutical Co.,Ltd's total revenue sank by 22.9% to $2B since the same quarter in the previous year.

Its net income has increased by 19.7% to $76M since the same quarter in the previous year.

Based on the above factors, Wakamoto Pharmaceutical Co.,Ltd gets an overall score of 3/5.

ISIN	JP3991200001
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Exchange	TSE
CurrencyCode	JPY

Beta	0.63
Market Cap	12B
PE Ratio	59.89
Target Price	None
Dividend Yield	1.7%

ABOUT

Wakamoto Pharmaceutical Co.,Ltd

Wakamoto Pharmaceutical Co.,Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation; and Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co.,Ltd. in July 1943. Wakamoto Pharmaceutical Co.,Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.

4512.TSE · Wakamoto Pharmaceutical Co.,Ltd

-

Wakamoto Pharmaceutical Co.,Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Wakamoto Pharmaceutical Co.,Ltd using a moving average strategy